Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Acute Migraine
Interventions
DRUG

ZP-Zolmitriptan

ZP-Zolmitriptan single administration delivered via intracutaneous microneedle patch delivery system

DRUG

Placebo

Placebo patch(es) to match ZP-Zolmitriptan single administration delivered via intracutaneous microneedle patch delivery system (one or two patches)

Trial Locations (36)

27262

Peters Medical Research LLC, High Point

27405

Headache Wellness Center, PC, Greensboro

27607

North Carolina Clinical Research, Raleigh

27609

PMG Research of Raleigh, Raleigh

29464

Coastal Carolina Research Center, Mt. Pleasant

30281

Clinical Research Atlanta, Stockbridge

32720

Avail Clinical Research, LLC, DeLand

32763

Medical Research Group of Central Florida, Orange City

33634

Meridien Research, Tampa

37203

Nashville Neurosciences Group, Nashville

45227

CTI Clinical Research Center, Cincinnati

48104

Michigan Head Pain &Neurological Institute, Ann Arbor

49009

Westside Family Medical Center, P.C, Kalamazoo

55402

Clinical Research Institute, Inc., Minneapolis

63141

The Clinical Research Center, LLC, St Louis

65807

Clinvest/A Division of Banyan Group Inc., Springfield

68123

Nebraska Medical Research Institute, Bellevue

78130

Central Texas Health Research, New Braunfels

78229

Sylvana Research Associates, San Antonio

80230

Colorado Allergy & AsthmaCenters, PC, Denver

85306

Clinical Research Advantage, Inc./Thunderbird Internal Medicine, Glendale

90017

Downtown LA Research Center, Los Angeles

90404

California Medical Clinic for Headache, Santa Monica

91786

Empire Clinical Research, Upland

92011

The Research Center of Southern California, Carlsbad

92647

Allergy and Asthma Specialists Medical Group and Research Center, Huntington Beach

92691

Allergy & Asthma Associates of Southern California, Mission Viejo

95117

Allergy and Asthma Associates of Santa Clara Valley Research Center, San Jose

06905

Ki Health Partners, Stamford

02131

Boston Clinical Trials, Boston

02740

Novex Medical Research, New Bedford

02714

Northeast Medical Research Associates, Inc., North Dartmouth

02472

MedVadis Research Corporation, Watertown

03756

Dartmouth-Hitchcock Medical Center, Lebanon

08558

Princeton Center for Clinical Research, Skillman

22911-3568

Charlottesville Medical Research Center LLC, Charlottesville

All Listed Sponsors
lead

Zosano Pharma Corporation

INDUSTRY

NCT02745392 - Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine | Biotech Hunter | Biotech Hunter